CClinicalTrials.gg
CompletedNCT06771141Updated Jan 14, 2025

Virtual Reality Before Pediatric Endoscopy

An interventional study of Virtual Reality Video Session in Pediatric Anxiety Disorders, sponsored by Yuzuncu Yıl University. Completed at 1 site in Turkey. Open to participants aged 8 Years to 17 Years. Per ClinicalTrials.gov, last updated 2025-01-14.

Sponsored by Yuzuncu Yıl University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Jul 2024, registered Jan 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
8 Years to 17 Years
Sex
All
01

Study summary

Brief Summary: Clinical Study

The purpose of this clinical study is to evaluate whether the use of virtual reality (VR) before endoscopy reduces anxiety levels and positively impacts vital signs in children. This study aims to answer the following key questions:

Does the VR application reduce pre-endoscopy anxiety in children? Does the VR application improve vital signs such as heart rate, blood pressure, and oxygen saturation in children?

Researchers will compare the effects of the VR application with standard care to assess its effectiveness.

Participants:

The experimental group will undergo a 15-minute VR session before the endoscopy.

The control group will receive standard care without VR. Anxiety levels and vital signs will be measured throughout the study.

This study aims to explore whether VR technology can serve as an effective stress management tool during pediatric medical procedure

02

Conditions studied

  • Pediatric Anxiety Disorders

Browse trials for

Keywords

  • Virtual Reality, Anxiety, Endoscopy, Pediatric, Vital Signs
03

In context

Anxiety Disorders

4,874 studies on the registry are indexed under Anxiety Disorders; 1,394 are open to participants now.

This study's enrollment of 80 is close to the median of 80 across 4,180 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Yuzuncu Yıl University is the lead sponsor of 124 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Children aged 8 to 17 years.
  • Scheduled to undergo an endoscopy procedure.
  • Able to provide assent, and their parents or legal guardians provide written informed consent.
  • No prior exposure to virtual reality applications.
  • Willing to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Presence of a chronic medical condition affecting cardiovascular or respiratory systems.
  • Diagnosed with a severe psychiatric disorder.
  • Known visual or auditory impairments that could prevent participation in a virtual reality session.
  • History of seizures or epilepsy.
  • Unwillingness to participate or inability to comply with study procedures.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (actual)

Study arms

  • Experimental
    Virtual Reality Intervention Group

    This arm includes participants who will receive a 10-minute virtual reality (VR) session before their endoscopy procedure. The VR intervention aims to reduce anxiety and stabilize vital signs (e.g., systolic/diastolic blood pressure, heart rate, oxygen saturation) by providing an immersive and interactive experience designed to distract and relax the participants. Anxiety levels and vital signs will be measured pre- and post-intervention to evaluate its effectiveness.

    Behavioral: Virtual Reality Video Session

  • No intervention
    Standard Care Control Group

    Participants in this group will receive standard care prior to the endoscopy procedure, without the VR intervention. Anxiety levels and vital signs will be measured at similar intervals to compare with the experimental group.

Interventions

  • BehavioralVirtual Reality Video Session

    This intervention involves a 10-minute virtual reality (VR) video session designed to reduce pre-procedural anxiety and promote relaxation in pediatric patients. The video immerses participants in a calming virtual environment with interactive and visually engaging content tailored for children. It is administered prior to the endoscopy procedure to help manage anxiety and stabilize vital signs, such as blood pressure, heart rate, and oxygen saturation. The VR session serves as a non-pharmacological approach to anxiety management during medical procedures.

06

What researchers measure

Primary outcomes

  1. Reduction in Anxiety Levels in Pediatric Patients

    The primary outcome measure is the change in anxiety levels among pediatric patients undergoing endoscopy. Anxiety levels will be assessed using the State-Trait Anxiety Inventory for Children (STAIC), a validated tool for measuring anxiety in children. Scores will be measured before and after the intervention to determine the effectiveness of the virtual reality (VR) application compared to the control group receiving standard care.

    Time frame: Anxiety levels will be measured immediately before the intervention and immediately after the intervention on the same day as the endoscopy procedure.

07

Study locations

1 site
  • Van Yüzüncü Yıl Üniversity
    Van, 65000, Turkey
08

References and documents

Individual participant data

Plan to share: No — Individual Participant Data (IPD) will not be shared to prioritize the privacy and confidentiality of participants. Additionally, it has been specified in the ethical approval that the data will only be used for the purposes of this study and will not be shared with third parties.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 14, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06771141
Lead sponsor
Yuzuncu Yıl University
Responsible party
mehmet bulduk (PhD, Yuzuncu Yıl University) — Principal investigator
First posted
Jan 13, 2025
Start date
Jul 29, 2024
Primary completion
Nov 26, 2024
Completion
Dec 15, 2024
Last update
Jan 14, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion